D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4476
Sana Biotechnology
SANA
$698M
| $140K | ﹤0.01% |
40,090
+1,420
| +4% | +$4.58K |
2025 Q4
2 quarters
|
|
4477
Recursion Pharmaceuticals
RXRX
$1.98B
| $139K | ﹤0.01% |
37,914
-8,094
| -18% | -$26.9K |
2025 Q4
2 quarters
|
|
4478
Archer Aviation
ACHR
$3.01B
| $138K | ﹤0.01% |
29,114
-540,498
| -95% | -$3.14M |
2024 Q3
7 quarters
|
|
4479
Kayne Anderson BDC
KBDC
$843M
| $138K | ﹤0.01% |
10,167
-4,522
| -31% | -$65.2K |
2026 Q1
1 quarter
|
|
|
CCIXW
4480
DELISTED
Churchill Capital Corp IX Warrant
CCIXW
| $136K | ﹤0.01% |
175,000
| – | – |
2024 Q3
7 quarters
|
|
4481
AudioEye
AEYE
$102M
| $136K | ﹤0.01% |
23,450
-9,669
| -29% | -$67.3K |
2026 Q1
1 quarter
|
|
4482
LifeMD
LFMD
$103M
| $136K | ﹤0.01% |
+32,924
| New | +$145K |
2026 Q2
0 quarters
|
|
4483
Dakota Gold
DC
$707M
| $135K | ﹤0.01% |
31,754
-39,201
| -55% | -$212K |
2025 Q4
2 quarters
|
|
4484
CALL
Daqo New Energy
DQ
$690M
| $135K | ﹤0.01% |
10,100
-370,000
| -97% | -$6.72M |
2023 Q4
10 quarters
|
|
4485
Vendome Acquisition Corp I Warrant
VNMEW
| $135K | ﹤0.01% |
450,000
| – | – |
2025 Q3
3 quarters
|
|
4486
AH Realty Trust
AHRT
$455M
| $135K | ﹤0.01% |
19,048
+4,997
| +36% | +$32.1K |
2026 Q1
1 quarter
|
|
4487
Critical Metals Corp Warrants
CRMLW
$14.6M
| $135K | ﹤0.01% |
37,500
| – | – |
2025 Q4
2 quarters
|
|
4488
PUT
Conagra Brands
CAG
$7.09B
| $135K | ﹤0.01% |
10,000
-83,900
| -89% | -$1.17M |
2025 Q3
3 quarters
|
|
4489
FG Imperii Acquisition Corp
FGII
$290M
| $135K | ﹤0.01% |
+13,545
| New | +$134K |
2026 Q2
0 quarters
|
|
4490
Mobia Medical
MOBI
$347M
| $134K | ﹤0.01% |
+10,000
| New | +$129K |
2026 Q2
0 quarters
|
|
|
UCFI
4491
CN Healthy Food Tech Group
UCFI
| $131K | ﹤0.01% |
23,807
| – | – |
2025 Q4
2 quarters
|
|
4492
Integra Resources
ITRG
$448M
| $131K | ﹤0.01% |
57,707
-169,683
| -75% | -$458K |
2026 Q1
1 quarter
|
|
4493
Abacus Global Management
ABX
$812M
| $131K | ﹤0.01% |
+12,197
| New | +$111K |
2026 Q2
0 quarters
|
|
|
IPEXR
4494
DELISTED
Inflection Point Acquisition Corp V Rights
IPEXR
| $130K | ﹤0.01% |
200,000
| – | – |
2025 Q1
5 quarters
|
|
4495
Social Commerce Partners Warrant
SCPQW
| $129K | ﹤0.01% |
175,000
| – | – |
2026 Q1
1 quarter
|
|
4496
Medical Properties Trust
MPT
$1.61B
| $128K | ﹤0.01% |
27,718
-55,278
| -67% | -$274K |
2025 Q4
2 quarters
|
|
4497
Eagle Nuclear Energy Corp Warrants
NUCLW
$5.71M
| $127K | ﹤0.01% |
87,883
| – | – |
2026 Q1
1 quarter
|
|
4498
American Coastal Insurance
ACIC
$524M
| $127K | ﹤0.01% |
+11,422
| New | +$126K |
2026 Q2
0 quarters
|
|
4499
Pyrophyte Acquisition Corp II Warrants
PAII.WS
| $125K | ﹤0.01% |
250,000
| – | – |
2025 Q3
3 quarters
|
|
4500
Infinite Eagle Acquisition Corp Rights
IEAGR
| $122K | ﹤0.01% |
625,000
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.